These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29535737)

  • 41. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
    PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FasL shedding is reduced by hypothermia in experimental stroke.
    Liu L; Kim JY; Koike MA; Yoon YJ; Tang XN; Ma H; Lee H; Steinberg GK; Lee JE; Yenari MA
    J Neurochem; 2008 Jul; 106(2):541-50. PubMed ID: 18410517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The caspase pathway as a possible therapeutic target in experimental pemphigus.
    Pacheco-Tovar D; López-Luna A; Herrera-Esparza R; Avalos-Díaz E
    Autoimmune Dis; 2011 Mar; 2011():563091. PubMed ID: 21403857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.
    Yeh CN; Chung WH; Su SC; Chen YY; Cheng CT; Lin YL; Chang WC; Chung-Yee Hui R; Chiang KC; Chen TW; Jan YY; Chen CW; Chen TJ; Yang CH; Hung SI
    J Invest Dermatol; 2014 Nov; 134(11):2768-2775. PubMed ID: 24802849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis.
    Bektas M; Jolly PS; Berkowitz P; Amagai M; Rubenstein DS
    J Biol Chem; 2013 Mar; 288(13):9447-56. PubMed ID: 23404504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
    Dupont PJ; Warrens AN
    Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
    Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
    Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
    Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
    J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.
    Grando SA; Bystryn JC; Chernyavsky AI; Frusić-Zlotkin M; Gniadecki R; Lotti R; Milner Y; Pittelkow MR; Pincelli C
    Exp Dermatol; 2009 Sep; 18(9):764-70. PubMed ID: 19555352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pemphigus: the promises of peptide immunotherapy.
    Di Bisceglie MB; Lucchese A; Crincoli V
    Immunopharmacol Immunotoxicol; 2009; 31(4):509-15. PubMed ID: 19874216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The final destiny of acantholytic cells in pemphigus is Fas mediated.
    Pacheco-Tovar MG; Avalos-Díaz E; Vega-Memije E; Bollain-y-Goytia JJ; López-Robles E; Hojyo-Tomoka MT; Domínguez-Soto L; Herrera-Esparza R
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):697-701. PubMed ID: 19470049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.
    Gil MP; Modol T; España A; López-Zabalza MJ
    Exp Dermatol; 2012 Apr; 21(4):254-9. PubMed ID: 22320676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pemphigus, a pathomechanism of acantholysis.
    Furue M; Kadono T
    Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris?
    Caldarola G; Feliciani C
    Expert Rev Clin Immunol; 2011 Mar; 7(2):187-91. PubMed ID: 21426256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N; Gombos F; Lanza A
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3.
    Fan JL; Memar O; McCormick DJ; Prabhakar BS
    J Immunol; 1999 Dec; 163(11):6228-35. PubMed ID: 10570315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus.
    Sigmund AM; Winkler M; Engelmayer S; Kugelmann D; Egu DT; Steinert LS; Fuchs M; Hiermaier M; Radeva MY; Bayerbach FC; Butz E; Kotschi S; Hudemann C; Hertl M; Yeruva S; Schmidt E; Yazdi AS; Ghoreschi K; Vielmuth F; Waschke J
    Nat Commun; 2023 Jan; 14(1):116. PubMed ID: 36624106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pemphigus vulgaris and its active disease mouse model.
    Amagai M
    Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.